In the global pharmaceutical and nutraceutical landscape, Magnolia officinalis, known as "Hou Po" in Traditional Chinese Medicine (TCM), has transitioned from a classical decoction staple to a high-value industrial raw material. As leading Magnolia Herb Suppliers & Exporters, Neo-Green Herbs integrates 2,000 years of ethnobotanical wisdom with modern supercritical fluid extraction (SFE) and spray-drying granulation technologies.
Our Magnolia granules are standardized for Honokiol and Magnolol content. These polyphenolic compounds are the primary bio-actives responsible for the herb's neuroprotective, anti-inflammatory, and anxiolytic properties. Unlike raw powders, our granules ensure a 99% dissolution rate and molecular consistency.
Utilizing "Fingerprint Technology," we ensure every batch of Magnolia granules matches the chemical profile of the "Daodi" (authentic source) herb. We eliminate heavy metals and pesticide residues through a multi-stage purification process that exceeds USP and EU Pharmacopoeia standards.
With the rise of "Clean Label" supplements in North America and Europe, Magnolia extracts are increasingly used in functional beverages and stress-relief formulations. Neo-Green Herbs provides the regulatory documentation (COA, MSDS, GMP) required for seamless international trade.
Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd., was founded in 2023. We inherit a legacy of innovation from NGP, a titan in the TCM industry with total assets exceeding 30 billion RMB.
As one of only six pilot manufacturers approved by the Chinese government for TCM granule production, NGP represents the pinnacle of "Smart TCM" manufacturing. Our mission is to empower global pharmacies and clinics through an efficient B2B supply chain that bridges the gap between ancient wisdom and modern science.
Implementing AI-driven spectroscopic analysis for real-time quality monitoring during the extraction of Magnolia herb. This ensures "zero-defect" batches for the export market.
Expanding our "New Circular Economy" model. Magnolia bark harvesting is transitioning to a sustainable "peeling and regrowth" cycle to protect biodiversity in the Sichuan and Hubei regions.
Every sachet of TCM granules will feature a unique QR code linked to a blockchain, tracing the Magnolia herb from the specific mountain plot to the final extraction facility.
In an era of global logistical uncertainty, Neo-Green Pharmaceutical stands as a pillar of reliability. Our supply chain resilience is built on three core advantages:
We control the entire process from seed breeding and GAP-certified planting to smart warehousing. This eliminates middle-man markups and ensures stable pricing for our international partners.
With dozens of billions invested in 300+ production bases across Jiangxi, Yunnan, and Chongqing, our "Southwest TCM Hub" ensures that even during peak demand, we can fulfill large-scale OEM/ODM orders.
Our California-based subsidiary provides localized customer service, ensuring that technical support and regulatory guidance are available in the same time zone as our US and Canadian clients.
The global market for Magnolia Bark Extract is projected to grow at a CAGR of 6.5% through 2030. Key drivers include:
Neo-Green Herbs sits at the intersection of these industries, providing medical-grade granules that serve as the gold standard for global exporters.
Partner with Neo-Green Herbs for a stable, certified, and technologically advanced supply chain.
Contact Us Today
Neo-Green Herbs
